 
                            
                                    Cancer                                
                                                            ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
 
                             
                            
                                    Featured News                                
                                                            October 17, 2016
                                 
                             
                             
                             
                             
                            Sign up to receive email notifications
Explore more topics
 Sign up
 Sign up
               
                              Mayo Clinic Connect
An online patient support community
 
                            